TIAA CREF INVESTMENT MANAGEMENT LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$130,000
+16.1%
97,364
-1.5%
0.00%
Q4 2018$112,000
-79.5%
98,840
-50.0%
0.00%
Q3 2018$546,000
+3.4%
197,680
+33.7%
0.00%
Q2 2018$528,000
+5.6%
147,835
-9.3%
0.00%
Q1 2018$500,000
-32.5%
162,919
+38.5%
0.00%
Q4 2017$741,000
-11.5%
117,653
-3.9%
0.00%
-100.0%
Q3 2017$837,000
+17.6%
122,422
+22.5%
0.00%
Q2 2017$712,000
-52.1%
99,919
-38.2%
0.00%
-100.0%
Q1 2017$1,486,000
+189.7%
161,687
+27.1%
0.00%
Q4 2016$513,000
-33.3%
127,172
-36.7%
0.00%
Q3 2016$769,000
-22.5%
200,780
-13.0%
0.00%
-100.0%
Q2 2016$992,000
+18.2%
230,758
+27.4%
0.00%0.0%
Q1 2016$839,000
-53.8%
181,1360.0%0.00%0.0%
Q4 2015$1,817,000
+33.7%
181,136
-0.6%
0.00%0.0%
Q3 2015$1,359,000
-81.8%
182,196
+15.9%
0.00%
-80.0%
Q2 2015$7,454,000
+93.5%
157,135
+49.4%
0.01%
+66.7%
Q1 2015$3,853,000
+0.2%
105,145
+8.6%
0.00%0.0%
Q4 2014$3,845,000
+142.1%
96,820
+21.7%
0.00%
+200.0%
Q3 2014$1,588,000
+40.9%
79,579
-4.7%
0.00%0.0%
Q2 2014$1,127,000
+127.2%
83,523
+83.5%
0.00%
Q1 2014$496,000
-19.3%
45,5190.0%0.00%
Q4 2013$615,000
+18.7%
45,5190.0%0.00%
Q3 2013$518,000
+65.5%
45,519
+2.3%
0.00%
Q2 2013$313,00044,4860.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders